Intraperitoneal instillation of local anaesthetic (IPILA) in laparoscopic bariatric surgery
Phase 4
Completed
- Conditions
- Bariatric surgeryPost-operative painObesityAnaesthesiology - Pain managementSurgery - Surgical techniquesDiet and Nutrition - Obesity
- Registration Number
- ACTRN12618000389202
- Lead Sponsor
- Dr Nicholas Williams
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Patients who are undergoing a laparoscopic bariatric procedure through Riverina Bariatrics
Exclusion Criteria
allergy to local anaesthetic, severe cardiovascular disease (congestive heart failure or ischaemic heart disease), chronic renal disease (creatinine clearance <60 mL/h), child-Pugh Score B/C and if the participant declined to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-operative pain assessed using the 100mm visual analogue scale [Post-operatively in recovery at 1 & 2 hours and at 4, 8, 24, 48 hours. ]
- Secondary Outcome Measures
Name Time Method Morphine consumption or morphine equivalents post-operatively in mg/kg which will be assessed by examining post-operative medication charts and patient records. [In recovery at 2 hours and at 24 and 48 hours post-operatively.];Length of stay post-operatively which will be assessed by examining patient's hospital records. [Measured at time of discharge]